Androgen receptor status is highly conserved during tumor progression of breast cancer

BACKGROUND: With the advent of new and more efficient anti-androgen drugs targeting androgen receptor (AR) in breast cancer (BC) is becoming an increasingly important area of investigation. This would potentially be most useful in triple negative BC (TNBC), where better therapies are still needed. T...

Descripción completa

Detalles Bibliográficos
Autores principales: Grogg, André, Trippel, Mafalda, Pfaltz, Katrin, Lädrach, Claudia, Droeser, Raoul A., Cihoric, Nikola, Salhia, Bodour, Zweifel, Martin, Tapia, Coya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4640208/
https://www.ncbi.nlm.nih.gov/pubmed/26552477
http://dx.doi.org/10.1186/s12885-015-1897-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4640208/
https://www.ncbi.nlm.nih.gov/pubmed/26552477
http://dx.doi.org/10.1186/s12885-015-1897-2

Ejemplares similares